Key Highlights

● WM Technology clawed back some ground from its 52-week low of roughly $0.31, trading near $0.40 in mid-August 2026.

● Shares remain down more than 60% over the past year despite the recent modest recovery.

● An August 6 Earnings report showed a familiar pattern: improving profitability metrics diverging from a shrinking Revenue base.

● WM Technology, parent of the cannabis marketplace Weedmaps, trades over-the-counter after voluntarily delisting from Nasdaq.

WM Technology Inc., parent of the cannabis marketplace Weedmaps, has clawed back some ground from its 52-week low of roughly $0.31, trading near $0.40 in mid-August 2026, still down more than 60% over the past year. The move follows an August 6 earnings report that showed a familiar pattern for MAPS: shrinking revenue and client counts, but improved GAAP Net Income and a fortress-like cash balance. The stock jumped double digits the day results were released, though the company's shares have traded exclusively on the OTC market since a voluntary Nasdaq delisting completed in April. Investors weighing the story now must separate a genuine profitability improvement from a cannabis-tech marketplace that keeps getting smaller.

Latest Development

WM Technology reported second-quarter 2026 results on August 6, after market close. Revenue came in at $42.4 million, down 5.4% from $44.8 million in the prior-year period. GAAP net income rose to $2.9 million from $2.2 million a year earlier, while adjusted EBITDA fell sharply to $5.0 million from $11.7 million, a 57% year-over-year decline. Shares rose roughly 17% on the trading day the results were released, according to price-history data, though the size of the move on a thinly traded, sub-dollar OTC stock should be treated cautiously; no single company-specific announcement beyond the earnings release itself could be independently verified as fully explaining the reaction. For Q3 2026, management guided to a mid-single-digit percentage sequential revenue decline from Q2 levels.

Separately, the company's 10-Q disclosed legal housekeeping: a proposed $7.5 million settlement of a securities class action tied to prior monthly-active-user disclosures (with a final court approval hearing set for January 2027) and a related derivative-suit settlement involving governance reforms, with preliminary court approval expected August 31, 2026.

What the Numbers Show

The quarter continued a now multi-quarter pattern for WM Technology: a marketplace in gradual contraction that is nonetheless generating GAAP profit. Average monthly paying clients, dispensaries and brands that pay for Weedmaps listings and advertising, fell to 5,040 in Q2 2026 from 5,241 a year earlier, a decline of about 3.8%. Average monthly revenue per client slipped to $2,807 from $2,852. For the first six months of 2026, revenue totaled $86.0 million, down 3.9% from $89.5 million in the same period of 2025, while six-month adjusted EBITDA fell to $10.8 million from $21.9 million, a decline of more than 50%.

The adjusted EBITDA compression stands out against the net income improvement, a divergence that suggests non-operating items (such as changes in stock-based compensation, tax provisions, or legal-related charges) are cushioning the Bottom Line even as core marketplace profitability erodes. The 10-Q also flagged a rising allowance for Credit losses, which increased to $8.4 million from $4.2 million at year-end 2025, attributed to aging receivables and financial pressure among cannabis retail customers, a signal worth watching given WM Technology's heavy reliance on the California market, which the company has historically said accounts for well over half of revenue.

On the balance sheet, cash and equivalents stood at $60.5 million as of June 30, 2026, down modestly from $62.4 million at year-end 2025 but still substantial relative to the company's roughly $45 million OTC market capitalization, a gap that value-oriented investors have flagged, though it also reflects the market's skepticism about further cash burn and the illiquidity discount attached to OTC-quoted shares. WM Technology had approximately 159.7 million total Class A and Class V shares outstanding as of early August 2026.

Why Investors Are Paying Attention

Two threads are pulling at MAPS shares simultaneously. The first is company-specific: a Business that continues to lose paying clients and revenue in a maturing, oversupplied legal cannabis retail market, particularly in California, yet has managed to stay GAAP profitable while holding a large cash cushion relative to its market value. The second is macro and regulatory: the long-running federal effort to reschedule marijuana from Schedule I to Schedule III of the Controlled Substances Act. That process advanced in April 2026 when the DEA issued an order (effective April 28, 2026) moving FDA-approved Marijuana Products and state-licensed medical marijuana into Schedule III, while unlicensed and recreational cannabis remained Schedule I. An expedited DEA administrative hearing on broader rescheduling ran from June 29 to July 15, 2026, with post-hearing briefs due August 17, 2026, and an administrative law judge's recommendation not expected until later in 2026, meaning any final rescheduling decision remains months away, likely into 2027.

Bull Case

Bulls point to WM Technology's cash-rich Balance Sheet relative to its depressed market cap, continued GAAP profitability even as revenue contracts, and management's stated discipline on expenses. A favorable outcome from the ongoing DEA rescheduling process, even incremental, such as expanded banking access or reduced 280E tax burdens for cannabis operators, could ease financial pressure on Weedmaps's dispensary clients and stabilize or grow the client base. The company's move off Nasdaq was framed by management as reducing compliance costs and increasing operational flexibility.

Bear Case

Bears note that paying clients and average revenue per client have both declined year-over-year for multiple consecutive quarters, adjusted EBITDA has been cut roughly in half, and Q3 guidance points to further sequential revenue softness. The OTC delisting sharply reduces institutional ownership eligibility, analyst coverage, and share liquidity, and the rising credit-loss allowance suggests financial stress is spreading among the dispensary customers Weedmaps depends on. Ongoing securities and derivative litigation, while being settled, still carries execution and cost risk. Rescheduling timelines have repeatedly slipped in past cycles, and a final DEA determination is not expected imminently.

What Could Move the Stock Next?

Near-term catalysts include the August 17, 2026 post-hearing brief deadline in the DEA rescheduling proceeding, the August 31 preliminary court approval hearing on the derivative-suit settlement, Q3 2026 earnings (expected around November based on the company's historical reporting cadence), and any update on client-count or credit-loss trends. Broader cannabis-sector sentiment, OTC Liquidity conditions, and any state-level legalization or tax-policy news in large markets like California could also move shares given the stock's thin float and history of sharp single-day swings.

A Profitable Path on a Smaller Base

WM Technology's Q2 2026 results capture a company in a difficult position: a shrinking core marketplace business offset by expense discipline that has kept it GAAP-profitable, sitting on a cash pile that dwarfs its OTC-market valuation. The stock's recent uptick from 52-week lows coincided with the August 6 earnings release, though the durability of that move is unclear given the shares' thin, Delisted trading environment. The bigger swing factor, federal cannabis rescheduling, remains unresolved, with the administrative process not expected to reach a final decision until sometime in 2027. Investors following MAPS should watch client-count trends, credit-loss trajectory, and rescheduling-process milestones rather than reading too much into single-day price moves on this now-illiquid, sub-dollar security.